EPIDERMOLYSIS BULLOSA DYSTROPHICA
Clinical trials for EPIDERMOLYSIS BULLOSA DYSTROPHICA explained in plain language.
Never miss a new study
Get alerted when new EPIDERMOLYSIS BULLOSA DYSTROPHICA trials appear
Sign up with your email to follow new studies for EPIDERMOLYSIS BULLOSA DYSTROPHICA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Custom skin patch tested on one patient with severe blistering condition
Disease control OngoingThis study tests a lab-made skin substitute on a single patient with dystrophic epidermolysis bullosa, a rare disease that causes fragile, blistering skin. The graft is designed to cover chronic wounds that haven't healed with standard treatments. The goal is to see if the graft …
Matched conditions: EPIDERMOLYSIS BULLOSA DYSTROPHICA
Phase: EARLY_PHASE1 • Sponsor: CHU de Quebec-Universite Laval • Aim: Disease control
Last updated May 17, 2026 05:32 UTC
-
Smartphone app could spot deadly skin cancer in rare disease patients
Diagnosis OngoingThis study is creating an artificial intelligence (AI) app that can spot a type of skin cancer called squamous cell carcinoma (SCC) in people with recessive dystrophic epidermolysis bullosa (RDEB), a rare blistering condition. SCC is the leading cause of death in adults with RDEB…
Matched conditions: EPIDERMOLYSIS BULLOSA DYSTROPHICA
Sponsor: Northwestern University • Aim: Diagnosis
Last updated May 17, 2026 05:48 UTC